Saturday, October 3, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

BrainChip Secures Key Licensing Agreement for Akida-2 Technology

Rodolfo Hanigan by Rodolfo Hanigan
March 31, 2026
in AI & Quantum Computing, Semiconductors, Tech & Software, Trading & Momentum
0
BrainChip Stock
0
SHARES
62
VIEWS
Share on FacebookShare on Twitter

The neuromorphic computing specialist BrainChip has announced a significant commercial milestone, signaling a potential turnaround after a prolonged period of limited news. The company entered into a global licensing agreement with EDGEAI over the weekend, granting access to its next-generation Akida-2 technology. This deal reinforces a fundamental recovery that was initially hinted at in the firm’s latest annual revenue figures.

Under the terms of the non-exclusive partnership, EDGEAI receives comprehensive access to the intellectual property underpinning BrainChip’s Akida architecture. The agreement also includes necessary development tools and software components. Financial returns for BrainChip will come through milestone-based payments linked to technical delivery targets. Once EDGEAI begins commercial shipment of its own products, quarterly royalty payments will commence. While management has not yet quantified the precise financial scope, it anticipates substantial long-term revenue streams from resulting product sales.

Should investors sell immediately? Or is it worth buying BrainChip?

Financial Performance Shows Marked Improvement

This new contract aligns with a broader positive shift in the company’s financial trajectory. The annual report for 2025, published in late February, revealed a dramatic 374 percent surge in revenue to $1.89 million. Concurrently, BrainChip managed to narrow its net loss from $24.43 million to $20.47 million. The company also strengthened its balance sheet, with cash reserves growing to $31.71 million. Investor sentiment has responded with cautious optimism. The equity, currently trading at €0.09, is attempting to stabilize following an approximate 28 percent decline over the preceding twelve-month period.

Operational Milestones on the Horizon

Beyond commercial deals, operational execution is now coming into focus. The company reports that its AKD1500 chip has entered the volume production phase, with final silicon expected in the third quarter of 2026. In parallel, development has commenced on the custom AKD2500 project. First prototypes for this chip are also slated for availability in Q3 2026. These technological advancements form the foundation for BrainChip to more broadly address rising demand for ultra-low-power AI applications within the edge computing sector.

Ad

BrainChip Stock: Buy or Sell?! New BrainChip Analysis from October 3 delivers the answer:

The latest BrainChip figures speak for themselves: Urgent action needed for BrainChip investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from October 3.

BrainChip: Buy or sell? Read more here...

Tags: BrainChip
Rodolfo Hanigan

Rodolfo Hanigan

Related Posts

Micron Technology Stock
AI & Quantum Computing

Micron’s Rally Faces Its Moment of Reckoning: A Downgrade, a Labor Standoff, and a Date With the Numbers

September 9, 2026
SAP Stock
Analysis

SAP’s Buyback Machine Grinds On, But the Analyst Chorus Is Turning Sour

September 7, 2026
Xiaomi Stock
Asian Markets

Xiaomi’s September Tightrope: A Foldable Counterpunch Against Apple While EV Targets Slip

September 7, 2026
Next Post
Nexus Uranium Stock

Nexus Uranium Shifts Focus to Project Exploration Following Strategic Acquisitions

Orsted Stock

Bank of America Upgrade Ignites Surge in Ørsted Shares

Roche Stock

Roche's Diagnostic Division Gains Momentum with Dual Regulatory Wins

Recommended

American States Water Stock

American States Water: Dividend Champion Faces Operational Headwinds

1 year ago
Biotechnology Markets and money

Introducing the OBIS 640 XT Revolutionizing SuperResolution Microscopy

3 years ago
SunHydrogen Stock

SunHydrogen’s Outdoor Pilot Project Signals Potential Green Hydrogen Advancement

12 months ago
Lockheed Stock

Defense Stock Dilemma: Can Lockheed Martin Weather Peace Talks?

10 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum DroneShield Eli Lilly FALLBACK Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Robinhood Rocket Lab USA Salesforce Strategy Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

The Rate Plateau’s Real Winners Aren’t Chipmakers

The K-Shaped Economy Meets a 19-Year High in Yields

Consumer Strength Meets Bond Market Stress Ahead of Q4

Borrowed Bull: Record Margin Debt Meets a Record Foreign Inflow

Software Over Silicon: Microsoft’s Bet to Monetize the AI Boom

Shell’s Gas Ambitions Meet Buyback Discipline as LNG Canada Talks Take Shape

Trending

AMD Stock
Newsletter

Q4 Stock Picking: Where Scarcity Is Priced In, and Where It Isn’t

by Stephanie Dugan
October 3, 2026
0

Dear readers, Friday's edition showed how selective spending has become, with Nike punished for its guidance and...

Nike Stock

Nike Sinks to a 13-Year Low While Tesla and Amazon Find Buyers

October 2, 2026
Alphabet Stock

From GPUs to Guardrails: Q4’s Security Rotation Begins

October 1, 2026
Charles Schwab Stock

The Rate Plateau’s Real Winners Aren’t Chipmakers

September 30, 2026
Nvidia Stock

The K-Shaped Economy Meets a 19-Year High in Yields

September 29, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Q4 Stock Picking: Where Scarcity Is Priced In, and Where It Isn’t
  • Nike Sinks to a 13-Year Low While Tesla and Amazon Find Buyers
  • From GPUs to Guardrails: Q4’s Security Rotation Begins

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com